Stock Market Reviews

ZYXI (Zynex, Inc.) News

Get the latest news, insights, and market updates on ZYXI (Zynex, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the arrival of newly appointed CEO, Steven Dyson, and the appointment of several new leaders at the Company.
  Aug 18, 2025 - $ZYXI
• Zynex Inc. (ZYXI) Reports Q2 Loss, Misses Revenue Estimates
  Zynex (ZYXI) delivered earnings and revenue surprises of -60.00% and -17.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
  Jul 31, 2025 - $ZYXI
• Zynex Reports Second Quarter 2025 Financial Results
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the second quarter ended June 30, 2025.
  Jul 31, 2025 - $ZYXI
• Zynex Sets Second Quarter 2025 Earnings Call
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Thursday, July 31, 2025 at 4:15 PM Eastern Time to discuss its financial results for the second quarter ended June 30, 2025. Financial results will be issued in a press release prior to the call.
  Jul 22, 2025 - $ZYXI
• Tricare Temporary Payment Suspension Update
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company received an update from Tricare that the temporary payment suspension will continue.
  Jul 2, 2025 - $ZYXI
• Zynex Announces Steven Dyson as New CEO
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Steven Dyson as Chief Executive Officer. His employment will begin on August 18, 2025.
  Jun 30, 2025 - $ZYXI
• Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor.
  Jun 25, 2025 - $ZYXI
• Here’s Why Zynex (ZYXI) Fell in Q1
  Rewey Asset Management, an investment management company, released its “RAM Smid Composite” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The composite declined 6.97% in Q1 2025, trailing a 5.83% decline for the benchmark Russell 2500 Value Total Return Index. Larger-cap stocks outperformed smaller ones in 1Q25, with the […]
  May 23, 2025 - $ZYXI
• Zynex announces submission of 510(k) application for laser pulse oximeter
  The company's laser technology will facilitate the accurate measurement of oxygen levels for patients with darker skin pigmentation.
  May 13, 2025 - $ZYXI
• Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter
  Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for its NiCO™, Noninvasive CO-Oximeter device.
  May 12, 2025 - $ZYXI